Although African trypanosomiasis, also known as sleeping sickness, has fallen in prominence to become extremely rare, the drug acoziborole may help the World Health Organization’s goal of eradicating the parasitic disease by 2030, according to researchers.
Read the full post on Becker's Hospital Review - Healthcare News
